60 Degrees Pharmaceuticals, Inc. (SXTP): Depreciation & Amortization
$43.3K
Year ended 2025-12-31
$61.0K
Trailing 12 months to 2026-06-30
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $43.3K | +269.5% | 2026-03-30, From 2025-01-01 |
| 2024-12-31 | $11.7K | -44.6% | 2026-03-30, From 2024-01-01 |
| 2023-12-31 | $21.2K | n/a | 2025-03-27, From 2023-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 2025-12-31 | $43.3K | +269.5% |
| Shattuck Labs, Inc. (STTK) | 2025-12-31 | $3.70M | -2.6% |
| Dare Bioscience, Inc. (DARE) | 2025-12-31 | $1.63M | n/m |
| Rafael Holdings, Inc. (RFL) | 2025-07-31 | $288.0K | +28.0% |
| China SXT Pharmaceuticals, Inc. (SXTC) | 2026-03-31 | $73.7K | -10.5% |
| Neuphoria Therapeutics Inc. (NEUP) | 2026-06-30 | $663.0K | 0.0% |
| Rallybio Corp (RLYB) | 2025-12-31 | $92.0K | -29.8% |
| Longeveron Inc. (LGVN) | 2025-12-31 | $800.0K | +14.3% |
| Onconetix, Inc. (ONCO) | 2025-12-31 | $15.2K | -97.9% |
Compare SXTP, STTK, DARE, RFL side by side · Screen every company in Pharmaceutical Preparations ↗